Q32 Bio Inc. Company Profile
NASDAQ: QTTBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 3:33 PM ET
Q32 Bio at a glance
Q32 Bio Inc. (NASDAQ: QTTB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Waltham, MA. Q32 Bio is led by Ms. Jodie Pope Morrison and employs about 22 people. The company's shares have traded publicly since 2018.
At a market capitalization of $237.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001661998, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Q32 Bio do?
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Q32 Bio Inc.
- Ticker
- NASDAQ: QTTB
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Ms. Jodie Pope Morrison
- Employees
- 22
- Headquarters
- 830 Winter Street, Waltham, MA, United States
- Phone
- 781 999 0232
- Website
- q32bio.com
- IPO year
- 2018
- Market cap
- $237.86M
- SEC CIK
- 0001661998
Companies similar to Q32 Bio
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KROSKeros Therapeutics Inc. | 12.00 | +3.09% | $237.93M | vs QTTB |
| MGNXMacroGenics Inc. | 3.75 | +5.49% | $238.56M | vs QTTB |
| SLGLSol-Gel Technologies Ltd. | 72.25 | +2.71% | $236.53M | vs QTTB |
| IFRXInflaRx N.V. | 1.61 | +4.90% | $236.53M | vs QTTB |
| SIGASIGA Technologies Inc. | 3.28 | -0.15% | $235.31M | vs QTTB |
| CAMPCAMP4 Therapeutics Corporation | 3.72 | +0.41% | $233.13M | vs QTTB |
| GLSIGreenwich LifeSciences Inc. | 15.88 | +4.89% | $233.09M | vs QTTB |
| PYXSPyxis Oncology Inc. | 2.04 | +2.26% | $243.09M | vs QTTB |